LEADER 04554nam 22006615 450 001 9910253942603321 005 20200706035249.0 010 $a3-319-59165-7 024 7 $a10.1007/978-3-319-59165-0 035 $a(CKB)3710000001631533 035 $a(MiAaPQ)EBC4947027 035 $a(DE-He213)978-3-319-59165-0 035 $a(PPN)203852621 035 $a(EXLCZ)993710000001631533 100 $a20170812d2017 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aSafety, Ethics and Regulations /$fedited by Phuc Van Pham, Achim Rosemann 205 $a1st ed. 2017. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2017. 215 $a1 online resource (330 pages) $cillustrations 225 1 $aStem Cells in Clinical Applications,$x2365-4198 311 $a3-319-59164-9 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aPart  I. Safety -- Chapter 1: The safety of allogeneic stem cell transplantation -- Chapter 2: Induced Pluripotent Stem Cell Therapy and Safety Concerns in Age-related Chronic Neurodegenerative Diseases -- Chapter 3: IClinical safety and applications of stem cell gene therapy -- Chapter 4:  The safety of non-expanded multipotential stromal cell therapies -- Part  II: Ethics and Regulations -- Chapter 5: A Normative Case for the Patentability of Human Embryonic Stem Cell Technologies -- Chapter 6. Ethical Considerations in Stem Cell Research on Neurologic and Orthopedic Conditions -- Chapter 7. New Regulatory Pathways for Stem Cell-Based Therapies: Comparison and Critique of Potential Models -- Chapter 8: Travelling cells ? Harmonised European Regualtion and the BAMI stem cell trial -- Chapter 9: Oversight and Evidence in Stem Cell Innovation: An Examination of International Guidelines -- Chapter 10: The regulation of clinical stem cell research in China -- Chapter 11: Gov erning Stem Cell Therapies in India -- Chapter 12: Patenting human embryonic stem cells in the European Union context: an updated analysis of a complex issue -- Chapter 13: The regulatory situation for clinical stem cell research in China -- Chapter 14: Contested Tissues: the donation of oocytes and embryos in the IVF-Stem Cell Interface in China -- Chapter 15: Challenges to international stem cell clinical trials in countries with diverging regulations. 330 $aThis invaluable resource discusses the saftey, ethics, and regulations of developing stem cell clinical applications. Each chapter is contributed by a preeminent scientist in the field and covers such topics as clinical safety of stem cell gene therapy, the patentability of hESC technologies, international guidelines, challenges to international stem cell clinical trials, worldwide regulations including in emerging markets like China and Taiwan. Saftey, Ethics, and Regulations and the other books in the Stem Cells in Clinical Applications series will be invaluable to scientists, researchers, advanced students and clinicians working in stem cells, regenerative medicine or tissue engineering. 410 0$aStem Cells in Clinical Applications,$x2365-4198 606 $aStem cells 606 $aRegenerative medicine 606 $aTissue engineering 606 $aMedical ethics 606 $aBioethics 606 $aStem Cells$3https://scigraph.springernature.com/ontologies/product-market-codes/L16010 606 $aRegenerative Medicine/Tissue Engineering$3https://scigraph.springernature.com/ontologies/product-market-codes/L16080 606 $aTheory of Medicine/Bioethics$3https://scigraph.springernature.com/ontologies/product-market-codes/H66000 606 $aBioethics$3https://scigraph.springernature.com/ontologies/product-market-codes/E14010 615 0$aStem cells. 615 0$aRegenerative medicine. 615 0$aTissue engineering. 615 0$aMedical ethics. 615 0$aBioethics. 615 14$aStem Cells. 615 24$aRegenerative Medicine/Tissue Engineering. 615 24$aTheory of Medicine/Bioethics. 615 24$aBioethics. 676 $a571.6 702 $aPham$b Phuc Van$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aRosemann$b Achim$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910253942603321 996 $aSafety, Ethics and Regulations$91954757 997 $aUNINA